(2S)-cyclopentyl 2-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yloxy)methyl)(phenoxy)phosphorylamino)propanoate

ID: ALA1095425

PubChem CID: 11519593

Max Phase: Preclinical

Molecular Formula: C24H28FN6O6P

Molecular Weight: 546.50

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@H](NP(=O)(CO[C@@H]1C=C(F)[C@H](n2cnc3c(N)ncnc32)O1)Oc1ccccc1)C(=O)OC1CCCC1

Standard InChI:  InChI=1S/C24H28FN6O6P/c1-15(24(32)35-16-7-5-6-8-16)30-38(33,37-17-9-3-2-4-10-17)14-34-19-11-18(25)23(36-19)31-13-29-20-21(26)27-12-28-22(20)31/h2-4,9-13,15-16,19,23H,5-8,14H2,1H3,(H,30,33)(H2,26,27,28)/t15-,19-,23+,38?/m0/s1

Standard InChI Key:  DTJVIZODBBCRCW-XHVABEAOSA-N

Molfile:  

     RDKit          2D

 38 42  0  0  0  0  0  0  0  0999 V2000
    2.5338   -5.3314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2755   -4.1097    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2573   -4.9354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9627   -5.3652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5157   -6.1572    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8285   -4.9016    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.9514   -3.3412    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    2.6241   -2.5740    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.1048   -5.2970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2310   -3.7462    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5215   -3.3257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5323   -2.5001    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8237   -2.0797    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1038   -2.4839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0970   -3.3129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8062   -3.7296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3614   -4.9462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2049   -5.5459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1905   -6.2698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0011   -6.1174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5318   -2.8894    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8810   -3.3934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1997   -2.9322    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4280   -2.1402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9923   -1.4388    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3813   -0.7143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2059   -0.6871    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.6414   -1.3843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2525   -2.1130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4467   -1.2151    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8060   -2.8373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4750   -3.3268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2157   -4.1137    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3907   -4.1112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1416   -3.3217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3518   -3.0570    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6982   -4.7826    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.7337   -3.6034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20  9  1  0
  1  6  1  0
  3  2  1  1
  7  8  2  0
  7  2  1  0
  1  3  1  0
  6  9  1  0
  3  4  1  0
  7 10  1  0
  1  5  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 21 29  1  0
 24 29  1  0
 28 30  1  0
 21 22  2  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 35 36  1  1
 31 32  1  0
 32 33  1  0
 33 34  2  0
 34 35  1  0
 31 35  1  0
 32 23  1  1
 33 37  1  0
  9 17  1  0
 36 38  1  0
 38  7  1  0
M  END

Associated Targets(Human)

PBMC (10003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MT2 (2907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasma (10718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasma (810 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus 1 (70413 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 546.50Molecular Weight (Monoisotopic): 546.1792AlogP: 3.83#Rotatable Bonds: 10
Polar Surface Area: 152.71Molecular Species: NEUTRALHBA: 11HBD: 2
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.36CX Basic pKa: 4.89CX LogP: 2.42CX LogD: 2.42
Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.28Np Likeness Score: 0.01

References

1. Mackman RL, Ray AS, Hui HC, Zhang L, Birkus G, Boojamra CG, Desai MC, Douglas JL, Gao Y, Grant D, Laflamme G, Lin KY, Markevitch DY, Mishra R, McDermott M, Pakdaman R, Petrakovsky OV, Vela JE, Cihlar T..  (2010)  Discovery of GS-9131: Design, synthesis and optimization of amidate prodrugs of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148.,  18  (10): [PMID:20409721] [10.1016/j.bmc.2010.03.041]

Source